Filing Details
CATALYST PHARMACEUTICALS, INC. (NASDAQ:CPRX) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event.
8k filedNASDAQ:CPRX
CATALYST PHARMACEUTICALS, INC. (CPRX) Reports Material Event to SEC
Filing Details CATALYST PHARMACEUTICALS, INC. (NASDAQ:CPRX) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event. Market…
Market Context
CATALYST PHARMACEUTICALS, INC.'s stock currently trades at $31.47 with a market capitalization of $2.8B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for CATALYST PHARMACEUTICALS, INC.'s stock.
All SEC filings for CATALYST PHARMACEUTICALS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CPRX Stock Page
Frequently Asked Questions
Where can I read CPRX's SEC filings?
Browse all filings on our CPRX SEC filings page.
What types of SEC filings does CATALYST PHARMACEUTICALS, INC. file?
Public companies like CATALYST PHARMACEUTICALS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.